Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 15, 2005
Towards a better understanding of the dissociation behavior of liposome-oligonucleotide complexes in the cytosol of cellsB Lucas, K Remaut, N N Sanders, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|February 16, 2005
FRET-FCS as a tool to evaluate the stability of oligonucleotide drugs after intracellular deliveryK Remaut, B Lucas, K Braeckmans, et al.Advanced Drug Delivery Reviews|November 3, 2004
Studying biophysical barriers to DNA delivery by advanced light microscopyS C De Smedt, K Remaut, B Lucas, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|November 22, 2005
Protection of oligonucleotides against nucleases by pegylated and non-pegylated liposomes as studied by fluorescence correlation spectroscopyK Remaut, B Lucas, K Braeckmans, et al.Thorax|October 31, 2006
Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosisN N Sanders, H Franckx, K De Boeck, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 15, 2005
Inulin is a promising cryo- and lyoprotectant for PEGylated lipoplexesW L J Hinrichs, N N Sanders, S C De Smedt, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|November 1, 2008
Ultradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytesB Geusens, J Lambert, S C De Smedt, et al.American Journal of Respiratory and Critical Care Medicine|November 9, 2000
Cystic fibrosis sputum: a barrier to the transport of nanospheresN N Sanders, S C De Smedt, E Van Rompaey, et al.Veterinary and Comparative Oncology|March 11, 2016
Immunological and angiogenic markers during metronomic temozolomide and cyclophosphamide in canine cancer patientsS Denies, L Cicchelero, H de Rooster, et al.Veterinary and Comparative Oncology|August 11, 2016
Intratumoural interleukin 12 gene therapy stimulates the immune system and decreases angiogenesis in dogs with spontaneous cancerL Cicchelero, S Denies, H Haers, et al.Pageof 3